Cytarabine Injection
Cytarabine Injection Specification
- Indication
- Used in the treatment of certain cancers such as leukemia (including acute myeloid leukemia, acute lymphocytic leukemia, and chronic myelogenous leukemia) and lymphomas.
- Dosage Form
- Liquid Injection
- Salt Composition
- Cytarabine
- Feature
- Sterile, pyrogen free, ready-to-use
- Ingredients
- Cytarabine and suitable excipients
- Application
- Intravenous or subcutaneous injection for oncology therapeutic use
- Ph Level
- Typically 7.0 - 8.5 (adjusted for injection preparation)
- Temperature Needed For Fermentation
- Not Applicable (Synthetic chemical preparation)
- Physical Color/Texture
- Clear, colorless to pale yellow liquid
- Fermentation Smell
- Odorless
- Shelf Life
- 24 months from manufacture date
- Strength
- Available as 100 mg/1 ml and 500 mg/5 ml vials
- Packaging Type
- Glass vial with flip-off seal
- Manufacturing Method
- Aseptic manufacturing under GMP guidelines
- Contraindications
- Hypersensitivity to Cytarabine or any component
- Administration Route
- Intravenous (IV) or Subcutaneous (SC)
- Prescription/Non Prescription
- Prescription
- USP/BP/EP Standards
- Meets pharmacopeial standards (USP/BP/EP)
- Compatibility
- Compatible with standard IV infusion fluids
Cytarabine Injection Trade Information
- Minimum Order Quantity
- 100 Piece
- Delivery Time
- 30 Days
- Sample Policy
- Within a certain price range free samples are available
- Certifications
- ISO, GMP, WHO

More Products in Oncology Drugs Category
Bortezomib Injection
Shelf Life : 2 years
Application : Other, Anticancer Therapy
Salt Composition : Bortezomib 2 mg/vial
Dosage Form : Lyophilized Powder for Injection
Fermentation Smell : Other, Odorless
Erlonat 150 Tablet
Minimum Order Quantity : 100
Shelf Life : 24 months
Application : Other, Oncology (anticancer therapy)
Salt Composition : Erlotinib Hydrochloride
Dosage Form : Tablet
Fermentation Smell : Other, Odorless
Get in touch with us

Send Inquiry




